Proper planning and training for MSLs on iPad usage is essential for success

NewsGuard 100/100 Score

The iPad is quickly supplanting laptops as the principal tool for enhancing Medical Science Liaisons' (MSLs) interactions with thought leaders. Despite this, deploying iPads requires significant planning, resources, and training to make the investment a success.

According to recent research by benchmarking firm, Best Practices, LLC, proper planning and training for MSLs on iPad usage is essential for success. While the study found that 92% of MSLs used iPads to present data to Key Opinion Leaders (KOLs), only 12% receive training on presentation skills. Reducing this gap should help to improve the effectiveness of MSL presentations.

The report, "The iPad: How MSLs Use It to Deliver Science and Data to HCPs," provides leaders with implementation plans, application strategy and evaluating measures that will equip executives to enhance MSL performance and successfully realize corporate investment in iPads. The report also identifies best practices and measures effectiveness for the successful deployment of iPads to MSLs.

Key study topics addressed include:

  • Training
  • Content Delivery & Usage
  • Syncing Tablets with CRM Systems
  • Security & Compliance Concerns
  • Measuring Effectiveness
  • Challenges & Best Practices

This benchmarking research drew participation from 25 Medical Affairs leaders at 18 companies through a benchmarking survey instrument. All participants share leadership and oversight of Medical Science Liaison (MSL) groups at their companies.

SOURCE Best Practices, LLC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis